These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2373993)

  • 21. The role of complement activation in atherosclerosis.
    Niculescu F; Rus H
    Immunol Res; 2004; 30(1):73-80. PubMed ID: 15258311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement regulation in murine and human hypercholesterolemia and role in the control of macrophage and smooth muscle cell proliferation.
    Verdeguer F; Castro C; Kubicek M; Pla D; Vila-Caballer M; Vinué A; Civeira F; Pocoví M; Calvete JJ; Andrés V
    Cardiovasc Res; 2007 Nov; 76(2):340-50. PubMed ID: 17673191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physical chemistry of the lipids of human atherosclerotic lesions. Demonstration of a lesion intermediate between fatty streaks and advanced plaques.
    Katz SS; Shipley GG; Small DM
    J Clin Invest; 1976 Jul; 58(1):200-11. PubMed ID: 932206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrous and lipid-rich atherosclerotic plaques are part of interchangeable morphologies related to inflammation: a concept.
    van der Wal AC; Becker AE; van der Loos CM; Tigges AJ; Das PK
    Coron Artery Dis; 1994 Jun; 5(6):463-9. PubMed ID: 7952404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of complement activation in atherogenesis: the first 40 years.
    Vlaicu SI; Tatomir A; Rus V; Mekala AP; Mircea PA; Niculescu F; Rus H
    Immunol Res; 2016 Feb; 64(1):1-13. PubMed ID: 26091721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of heat shock transcription factor 1 in atherosclerosis.
    Metzler B; Abia R; Ahmad M; Wernig F; Pachinger O; Hu Y; Xu Q
    Am J Pathol; 2003 May; 162(5):1669-76. PubMed ID: 12707051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteolytic transformation of SC5b-9 into an amphiphilic macromolecule resembling the C5b-9 membrane attack complex of complement.
    Bhakdi S; Bhakdi-Lehnen B; Tranum-Jensen J
    Immunology; 1979 Aug; 37(4):901-12. PubMed ID: 115783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoglobulins and complement components in human aortic atherosclerotic intima.
    Vlaicu R; Rus HG; Niculescu F; Cristea A
    Atherosclerosis; 1985 Apr; 55(1):35-50. PubMed ID: 2408631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Activation of human serum complement with inulin and purification of SC5b-9].
    Zhou FL; Kan D
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Aug; 13(4):293-7. PubMed ID: 1839526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Similarity in the distribution of F(2)-isoprostanes in the lipid subfractions of atherosclerotic plaque and in vitro oxidised low density lipoprotein.
    Waddington EI; Puddey IB; Mori TA; Croft KD
    Redox Rep; 2002; 7(3):179-84. PubMed ID: 12189049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoprotein degradation and cholesterol esterification in primary cell cultures of rabbit atherosclerotic lesions.
    Jaakkola O; Nikkari T
    Am J Pathol; 1990 Aug; 137(2):457-65. PubMed ID: 2201201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of interleukin-15 in mouse and human atherosclerotic lesions.
    Wuttge DM; Eriksson P; Sirsjö A; Hansson GK; Stemme S
    Am J Pathol; 2001 Aug; 159(2):417-23. PubMed ID: 11485899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mature human atherosclerotic plaque contains peroxidized phosphatidylcholine as a major lipid peroxide.
    Piotrowski JJ; Shah S; Alexander JJ
    Life Sci; 1996; 58(9):735-40. PubMed ID: 8632720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human aortic fibrolipid lesions. Progenitor lesions for fibrous plaques, exhibiting early formation of the cholesterol-rich core.
    Bocan TM; Guyton JR
    Am J Pathol; 1985 Aug; 120(2):193-206. PubMed ID: 4025509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of complement activation in atherosclerosis.
    Oksjoki R; Kovanen PT; Pentikäinen MO
    Curr Opin Lipidol; 2003 Oct; 14(5):477-82. PubMed ID: 14501586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential protective role of apoprotein J (clusterin) in atherogenesis: binding to enzymatically modified low-density lipoprotein reduces fatty acid-mediated cytotoxicity.
    Schwarz M; Spath L; Lux CA; Paprotka K; Torzewski M; Dersch K; Koch-Brandt C; Husmann M; Bhakdi S
    Thromb Haemost; 2008 Jul; 100(1):110-8. PubMed ID: 18612545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical colocalization of the terminal complex of human complement and smooth muscle cell alpha-actin in early atherosclerotic lesions.
    Torzewski M; Torzewski J; Bowyer DE; Waltenberger J; Fitzsimmons C; Hombach V; Gabbert HE
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2448-52. PubMed ID: 9409214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
    Hammer CH; Hänsch G; Gresham HD; Shin ML
    J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cytolytic C5b-9 complement complex: feedback inhibition of complement activation.
    Bhakdi S; Maillet F; Muhly M; Kazatchkine MD
    Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1912-6. PubMed ID: 3162317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for lipid peroxidation in atherosclerosis.
    Piotrowski JJ; Hunter GC; Eskelson CD; Dubick MA; Bernhard VM
    Life Sci; 1990; 46(10):715-21. PubMed ID: 2314193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.